日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Targeting pathogenic Th17.1 cells via JAK-STAT3 pathway: A novel approach with tofacitinib for refractory myasthenia gravis

通过JAK-STAT3通路靶向致病性Th17.1细胞:托法替尼治疗难治性重症肌无力的新方法

Zhao, Rui; Yan, Chong; Zhong, Huahua; Huan, Xiao; Jin, Lei; He, Dingxian; Xi, Jianying; Li, Yarong; Xiao, Baoguo; Luo, Feifei; Zhao, Chongbo; Song, Jie; Luo, Sushan

Predictors of exacerbation in myasthenia gravis after minimal symptom expression: a bicenter cohort study

重症肌无力症状轻微后病情加重的预测因素:一项双中心队列研究

He, Dingxian; Chen, Hongxi; Zhong, Huahua; Zhang, Nana; Yan, Chong; Song, Jie; Xi, Jianying; Luo, Sushan; Zhao, Chongbo; Zhou, Hongyu

Who Can Safely Discontinue Treatment in Myasthenia Gravis? Insights From a Long-Term Real-World Study

哪些重症肌无力患者可以安全停止治疗?一项长期真实世界研究的启示

He, Dingxian; Yan, Chong; Wang, Baitong; Yang, Yanlei; Gu, Shengying; Xi, Jianying; Luo, Sushan; Zhao, Chongbo

1-Year Clinical Outcome Post-Myasthenic Crisis: A Multicenter Prospective Study in China

重症肌无力危象后1年临床结局:一项中国多中心前瞻性研究

Huan, Xiao; Chen, Ran; Jin, Lei; Wang, Yuan; Xu, Yafang; Yang, Lei; Xi, Caihua; Zheng, Jianming; Luo, Lijun; Yang, Song; Shi, Jianquan; Liu, Yanping; Ruan, Zhe; Wu, Wanlong; Li, Wei; Yue, Yaoxian; Li, Yarong; Jia, Wenji; Zhong, Huahua; Yan, Chong; Song, Jie; Xi, Jianying; Tan, Song; Jiang, Qilong; Zou, Zhangyu; Zhao, Chongbo; Luo, Sushan

Rituximab for refractory ocular symptoms in myasthenia gravis with thyroid eye disease: a case report with quantitative MRI assessment

利妥昔单抗治疗伴有甲状腺眼病的重症肌无力难治性眼部症状:一例定量MRI评估病例报告

He, Dingxian; Li, Xiangwen; Wang, Baitong; Wang, Yaqi; Yan, Chong; Liu, Mengxiao; Hibert, Tom; Luo, Sushan; Zhao, Chongbo; Xi, Jianying

Serum cystatin C as a potential biomarker for generalized acetylcholine receptor antibody-positive myasthenia gravis.

血清胱抑素C作为全身性乙酰胆碱受体抗体阳性重症肌无力的潜在生物标志物

He Dingxian, Zhong Huahua, Jin Lei, Chen Ran, Wu Zongtai, Zhao Rui, Huan Xiao, Yan Chong, Song Jie, Xi Jianying, Zhao Chongbo, Zhu Shanfeng, Luo Sushan

Efgartigimod for induction and maintenance therapy in muscle-specific kinase myasthenia gravis

艾夫加替莫德用于肌肉特异性激酶型重症肌无力的诱导和维持治疗

Zhou, Yufan; Zhou, Qian; Yue, Yaoxian; Luo, Sushan; Song, Jie; Yan, Chong; He, Dingxian; Zhang, Jialong; Zhu, Wenhua; Zhao, Chongbo; Yang, Huan; Wang, Qinzhou; Xi, Jianying

A cohort of GFPT1 related congenital myasthenic syndrome in China: high frequency of c.331 c > t variant

中国一组GFPT1相关先天性肌无力综合征患者:c.331 c>t变异体频率高

Zhang, Jialong; Chen, Xinyu; Yan, Chong; Gu, Xinyu; Zhu, Wenhua; Cao, Xuwei; Zhou, Lei; Luo, Sushan; Lin, Jie; Li, Zunbo; Lu, Jiahong; Zhao, Chongbo; Qiao, Kai; Yu, Xuefan; Xi, Jianying

AB018. Targeted biologics for treating thymoma associated myasthenia gravis: a multicenter retrospective study

AB018. 靶向生物制剂治疗胸腺瘤相关重症肌无力:一项多中心回顾性研究

Schuldesz, Amanda Claudia; Tudor, Raluca; Cornea, Amalia; Geni, Dorina Nicola; Lata, Irina Nicoleta; Simu, Mihaela; Jin, Lei; He, Dingxian; Chen, Hongxi; Zhou, Hongyu; Zeng, Quantao; Tan, Song; Shi, Jianquan; Liu, Ying; Zou, Zhangyu; Song, Jie; Yan, Chong; Huan, Xiao; Wang, Yuan; Yang, Lei; Xi, Jianying; Wu, Zongtai; Zheng, Jianming; Zhao, Chongbo; Chu, Xianglin; Luo, Sushan

Autoimmune retinopathy in patients with myasthenia gravis: cases series and literature review

重症肌无力患者自身免疫性视网膜病变:病例系列及文献综述

Chen, Yiqiao; Zhang, Yexin; Luo, Jia; Liu, Miaomiao; Lin, Min; Zhu, Wenhua; Xiong, Wenjun; Zhao, Peiquan; Xi, Jianying; Fei, Ping